SANUWAVE Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	44.33	44.05	32.63	20.4	16.74	13.01
Revenue Growth (YoY)	22.52%	34.98%	59.99%	21.84%	28.69%	220.68%
Cost of Revenue	10.31	10.08	8.08	6.04	4.33	4.99
Gross Profit	34.02	33.97	24.55	14.36	12.41	8.02
Selling, General & Admin	28.44	26.79	19.24	13.57	20.03	20.28
Depreciation & Amortization Expenses	0.93	0.88	0.79	0.75	0.77	0.78
Research & Development	1.81	1.35	0.67	0.58	0.57	1.1
Total Operating Expenses	31.18	29.02	20.7	14.9	21.36	22.17
Operating Income	2.84	4.95	3.85	-0.54	-8.95	-14.14
Interest Expense	-4.94	-6.25	-13.78	-15.62	-14.13	-7.1
Other Non-Operating Income (Expense)	18.24	13.2	-23.13	-9.64	12.79	-5.99
Total Non-Operating Income (Expense)	13.3	6.95	-36.9	-25.26	-1.34	-13.09
Pretax Income	7.78	11.9	-33.06	-25.8	-10.29	-27.23
Provision for Income Taxes	-0.09	-0.09	-0.03	-0	-0	-0.03
Net Income	16.05	11.81	-33.08	-25.81	-10.29	-27.26
Net Income to Common	16.05	11.81	-33.08	-25.81	-10.29	-27.26
Shares Outstanding (Basic)	9	9	4	2	1	1
Shares Outstanding (Diluted)	9	9	4	2	1	1
Shares Change (YoY)	76.42%	103.51%	110.82%	44.47%	6.00%	37.09%
EPS (Basic)	1.87	1.38	-7.41	-11.25	-7.50	-18.75
EPS (Diluted)	1.76	0.41	-7.41	-11.25	-7.50	-18.75
Shares Outstanding	8.59	8.59	8.54	3.04	1.46	1.28
Free Cash Flow	0.7	1.93	1.97	-4.54	-17.17	-6.94
Free Cash Flow Growth	-63.91%	-1.58%	-	-	-	-
Free Cash Flow Per Share	0.08	0.21	0.44	-2.14	-11.72	-5.02
Gross Margin	76.74%	77.11%	75.23%	70.41%	74.13%	61.68%
Operating Margin	6.40%	11.23%	11.79%	-2.65%	-53.47%	-108.70%
Profit Margin	17.74%	27.21%	-101.21%	-126.48%	-61.46%	-209.09%
FCF Margin	1.57%	4.39%	6.02%	-22.25%	-102.55%	-53.33%
EBITDA	4.16	6.23	4.99	0.49	-8	-12.91
EBITDA Margin	9.38%	14.14%	15.30%	2.39%	-47.78%	-99.20%
EBIT	2.84	4.95	3.85	-0.54	-8.95	-14.14
EBIT Margin	6.40%	11.23%	11.79%	-2.65%	-53.47%	-108.70%
Effective Tax Rate	-1.11%	-0.72%	0.08%	0.02%	0.02%	0.10%

SEC Filings: 10-K · 10-Q